WALTHAM, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) reported that the time previously
announced for its presentation at the H.C.Wainwright 20th Annual Global Investment Conference has been
shifted to 10:00 am Eastern time on Thursday September 6, 2018. A live audio webcast will be available on the investor relations
section of the corporate website, www.NeuroMetrix.com. This webcast will be archived after the live event.
About
NeuroMetrix is an innovation driven healthcare company combining neurostimulation and digital medicine to address chronic
health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell®, an
over-the-counter wearable therapeutic device for chronic pain. The company also markets DPNCheck®, a rapid point-of-care
test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. For more information, please
visit NeuroMetrix.com.
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
Neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
